Page last updated: 2024-10-19

thioctic acid and Hematologic Malignancies

thioctic acid has been researched along with Hematologic Malignancies in 1 studies

Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhong, Y1
Meng, F1
Deng, C1
Mao, X1
Zhong, Z1

Other Studies

1 other study available for thioctic acid and Hematologic Malignancies

ArticleYear
Targeted inhibition of human hematological cancers in vivo by doxorubicin encapsulated in smart lipoic acid-crosslinked hyaluronic acid nanoparticles.
    Drug delivery, 2017, Volume: 24, Issue:1

    Topics: Animals; Cell Line, Tumor; Doxorubicin; Hematologic Neoplasms; Humans; Hyaluronic Acid; Mice; Mice,

2017